What are the guidelines for tapering Xanax (alprazolam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Tapering Xanax (Alprazolam)

A gradual tapering schedule with reductions of 25% of the initial dose every 1-2 weeks is the recommended approach for Xanax tapering to minimize withdrawal symptoms and risks. 1

Understanding Xanax Withdrawal Risks

  • Abrupt discontinuation of alprazolam can lead to serious consequences including seizures, rebound anxiety, and in rare cases, death 2
  • Withdrawal symptoms can range from mild dysphoria and insomnia to a major syndrome including abdominal and muscle cramps, vomiting, sweating, tremors, and convulsions 2
  • Withdrawal seizures have been reported even after brief therapy with alprazolam at doses within the recommended range (0.75 to 4 mg/day) 2
  • The risk of withdrawal seizures may be increased at doses above 4 mg/day 2

Recommended Tapering Protocol

  • Reduce the daily alprazolam dose by 25% every 1-2 weeks 1
  • For patients on higher doses (>4 mg/day) or long-term use, a more gradual taper may be necessary 2
  • The tapering process should be conducted under close medical supervision 2
  • Complete tapering within 6 months is generally recommended to avoid making the withdrawal process the central focus of the patient's life 3

Special Considerations

  • If the patient is also taking opioids, taper the opioids first, as benzodiazepine withdrawal carries greater risks than opioid withdrawal 4, 1
  • For elderly patients, consider a more gradual taper with smaller dose reductions 4
  • For high-dose users (>40 mg diazepam equivalent), inpatient management may be appropriate for the initial phase of tapering 5

Adjunctive Therapies

  • Cognitive-behavioral therapy (CBT) significantly increases tapering success rates and should be offered during the taper process 4, 1
  • Patient education about benzodiazepine risks and benefits of tapering improves outcomes and engagement 4, 1
  • Consider non-pharmacological approaches for anxiety management including mindfulness, relaxation techniques, and psychotherapy 4

Monitoring During Tapering

  • Monitor for withdrawal symptoms at each step of the taper 2
  • If severe withdrawal symptoms occur, temporarily hold at the current dose before resuming a more gradual taper 2
  • Distinguish between withdrawal symptoms (which tend to appear toward the end of taper or shortly after discontinuation and decrease with time) and recurrence of the original condition 2

Alternative Approaches

  • For some patients, substituting diazepam for alprazolam before tapering may be helpful due to diazepam's longer half-life and availability in liquid formulation for precise dosing 3
  • For triazolobenzodiazepines like alprazolam, some evidence suggests titrating at a rate of 0.5 mg three times a day may be appropriate 5

Common Pitfalls to Avoid

  • Never discontinue alprazolam abruptly, especially in patients with a history of seizures or epilepsy 2, 6
  • Don't taper too quickly, as this increases the risk of withdrawal symptoms and seizures 2
  • Avoid substituting other potentially addictive medications during the tapering process 3
  • Don't underestimate the importance of psychological support during the tapering process 1, 3

References

Guideline

Benzodiazepine Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Detoxification from benzodiazepines: schedules and strategies.

Journal of substance abuse treatment, 1991

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.